When you have atopic dermatitis, a form of eczema, it can be easy to dismiss symptoms like dry, itchy skin as normal for you. But even if you’re able to live with these symptoms, doing so can create a ...
How do dermatologists diagnose atopic dermatitis? To diagnose atopic dermatitis, also called eczema, a board-certified dermatologist carefully examines your (or your child's) skin and asks questions. ...
Hosted on MSN
Want to Switch Your Atopic Dermatitis Treatment? 5 Questions to Ask Your Dermatologist First
With atopic dermatitis, also known as eczema, you might go years on the same medication, experiencing minimal flares and sometimes none at all. Then suddenly you're dealing with itching, redness, rash ...
If you experience chronic dry, itchy and red skin, you may be one of the millions of Americans with eczema. The National Eczema Association reports that an estimated 10% of the world population ...
If you’re a person of color, finding the right treatment for atopic dermatitis, a common form of eczema, can be challenging. Even though the disease is more prevalent in Black Americans than white ...
Light therapy may work for people with stubborn eczema symptoms, but you should discuss the risks and benefits with a healthcare provider. Light therapy, also known as phototherapy, is a skin ...
Credit: Getty Images. Clinical phenotypes of atopic dermatitis can vary greatly based on skin color and can make atopic dermatitis difficult to diagnose. Recognizing the clinical diversity of ...
What are the 7 different eczema types? If you start to experience itchy skin, redness, and a rash-like appearance, you may have eczema, an umbrella term for a group of skin conditions. These hallmark ...
Despite a recent influx of new treatments, it is crucial to remind patients there is no cure for atopic dermatitis and follow-up care is important, explained Jerry Bagel, MD, director of the Eczema ...
Amlitelimab, an OX40 ligand–targeting therapy that modulates T-cell-mediated inflammation without causing cell depletion, ...
With shares down more than 40% since November, the risk-reward for Nektar Therapeutics has shifted ahead of pivotal clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results